These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 28210270

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study.
    Elsenbruch S, Rosenberger C, Enck P, Forsting M, Schedlowski M, Gizewski ER.
    Gut; 2010 Apr; 59(4):489-95. PubMed ID: 19651629
    [Abstract] [Full Text] [Related]

  • 23. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M, Hongo M, Fukudo S.
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome.
    Piché M, Arsenault M, Poitras P, Rainville P, Bouin M.
    Pain; 2010 Jan; 148(1):49-58. PubMed ID: 19889500
    [Abstract] [Full Text] [Related]

  • 26. Visceral hypersensitivity is together with psychological distress and female gender associated with severity of IBS-like symptoms in quiescent ulcerative colitis.
    Mavroudis G, Strid H, Jonefjäll B, Simrén M.
    Neurogastroenterol Motil; 2021 Mar; 33(3):e13998. PubMed ID: 33034406
    [Abstract] [Full Text] [Related]

  • 27. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S, Jonkers DM, Koning CJ, Kruimel JW, Mulder L, van der Vaart IB, Conchillo JM, Masclee AA.
    Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
    [Abstract] [Full Text] [Related]

  • 28. Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial.
    Kikuchi S, Oe Y, Sasaki Y, Ishii H, Ito Y, Horikoshi M, Sozu T, Seno H, Furukawa TA.
    BMC Gastroenterol; 2020 Feb 04; 20(1):29. PubMed ID: 32019509
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.
    van der Veek PP, Van Rood YR, Masclee AA.
    Clin Gastroenterol Hepatol; 2008 Mar 04; 6(3):321-8. PubMed ID: 18258487
    [Abstract] [Full Text] [Related]

  • 31. Abnormal forebrain activity in functional bowel disorder patients with chronic pain.
    Kwan CL, Diamant NE, Pope G, Mikula K, Mikulis DJ, Davis KD.
    Neurology; 2005 Oct 25; 65(8):1268-77. PubMed ID: 16247056
    [Abstract] [Full Text] [Related]

  • 32. Novel techniques to study visceral hypersensitivity in irritable bowel syndrome.
    Truong TT, Naliboff BD, Chang L.
    Curr Gastroenterol Rep; 2008 Aug 25; 10(4):369-78. PubMed ID: 18627648
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Stress and visceral pain: focusing on irritable bowel syndrome.
    Fukudo S.
    Pain; 2013 Dec 25; 154 Suppl 1():S63-S70. PubMed ID: 24021863
    [Abstract] [Full Text] [Related]

  • 37. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion.
    Caldarella MP, Milano A, Laterza F, Sacco F, Balatsinou C, Lapenna D, Pierdomenico SD, Cuccurullo F, Neri M.
    Am J Gastroenterol; 2005 Feb 25; 100(2):383-9. PubMed ID: 15667496
    [Abstract] [Full Text] [Related]

  • 38. Internet-Delivered Cognitive Behavior Therapy for Adolescents With Irritable Bowel Syndrome: A Randomized Controlled Trial.
    Bonnert M, Olén O, Lalouni M, Benninga MA, Bottai M, Engelbrektsson J, Hedman E, Lenhard F, Melin B, Simrén M, Vigerland S, Serlachius E, Ljótsson B.
    Am J Gastroenterol; 2017 Jan 25; 112(1):152-162. PubMed ID: 27845338
    [Abstract] [Full Text] [Related]

  • 39. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study.
    Kuiken SD, Tytgat GN, Boeckxstaens GE.
    Clin Gastroenterol Hepatol; 2003 May 25; 1(3):219-28. PubMed ID: 15017494
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.